BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17763140)

  • 1. Influence of impactor operating flow rate on particle size distribution of four jet nebulizers.
    Zhou Y; Brasel TL; Kracko D; Cheng YS; Ahuja A; Norenberg JP; Kelly HW
    Pharm Dev Technol; 2007; 12(4):353-9. PubMed ID: 17763140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of nebulizer performance under various humidity conditions.
    Zhou Y; Ahuja A; Irvin CM; Kracko D; McDonald JD; Cheng YS
    J Aerosol Med; 2005; 18(3):283-93. PubMed ID: 16181003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of flow pattern, device and formulation on particle size distribution of nebulized aerosol.
    Hu J; Zhang R; Beng H; Deng L; Ke Q; Tan W
    Int J Pharm; 2019 Apr; 560():35-46. PubMed ID: 30664994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer.
    Waldrep JC; Berlinski A; Dhand R
    J Aerosol Med; 2007; 20(3):310-9. PubMed ID: 17894537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of nebulizer droplet size distribution: a method based on impactor refrigeration.
    Berg E; Svensson JO; Asking L
    J Aerosol Med; 2007; 20(2):97-104. PubMed ID: 17536948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical nebulizer performance: effects of cascade impactor temperature.
    Zhou Y; Ahuja A; Irvin CM; Kracko DA; McDonald JD; Cheng YS
    Respir Care; 2005 Aug; 50(8):1077-82. PubMed ID: 16225713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerodynamic characteristics of nebulized terbutaline sulphate using the Andersen Cascade Impactor compared to the Next Generation Impactor.
    Abdelrahim ME
    Pharm Dev Technol; 2011 Apr; 16(2):137-45. PubMed ID: 20100034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of nebulized particle size distribution with Malvern laser diffraction analyzer versus Andersen cascade impactor and low-flow Marple personal cascade impactor.
    Kwong WT; Ho SL; Coates AL
    J Aerosol Med; 2000; 13(4):303-14. PubMed ID: 11262437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminating Ability of Abbreviated Impactor Measurement Approach (AIM) to Detect Changes in Mass Median Aerodynamic Diameter (MMAD) of an Albuterol/Salbutamol pMDI Aerosol.
    David Christopher J; Patel RB; Mitchell JP; Tougas TP; Goodey AP; Quiroz J; Andersson PU; Lyapustina S
    AAPS PharmSciTech; 2017 Nov; 18(8):3296-3306. PubMed ID: 28589305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of a procedure used to measure aerosol characteristics of nebulized solutions using a cooled next generation impactor.
    Berlinski A; Hayden JB
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):397-404. PubMed ID: 20958142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
    Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
    AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a droplet evaporation model to aerodynamic size measurement of drug aerosols generated by a vibrating mesh nebulizer.
    Rao N; Kadrichu N; Ament B
    J Aerosol Med Pulm Drug Deliv; 2010 Oct; 23(5):295-302. PubMed ID: 20455771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying Aerosol Delivery in Simulated Spontaneously Breathing Patients With Tracheostomy Using Different Humidification Systems With or Without Exhaled Humidity.
    Ari A; Harwood R; Sheard M; Alquaimi MM; Alhamad B; Fink JB
    Respir Care; 2016 May; 61(5):600-6. PubMed ID: 26908921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand.
    Hess D; Fisher D; Williams P; Pooler S; Kacmarek RM
    Chest; 1996 Aug; 110(2):498-505. PubMed ID: 8697857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a Nebulizer Holding Chamber on Aerosol Delivery.
    Sarhan RM; Elberry AA; Abdelwahab NS; Rabea H; Salem MN; Abdelrahim ME
    Respir Care; 2018 Sep; 63(9):1125-1131. PubMed ID: 29789412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerodynamic and electrostatic properties of model dry powder aerosols: a comprehensive study of formulation factors.
    Telko MJ; Hickey AJ
    AAPS PharmSciTech; 2014 Dec; 15(6):1378-97. PubMed ID: 24938617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining a positive expiratory pressure device with a metered-dose inhaler reservoir system using chlorofluorocarbon albuterol and hydrofluoroalkane albuterol: effect on dose and particle size distributions.
    Rau JL; Torniainen M
    Respir Care; 2000 Mar; 45(3):320-6. PubMed ID: 10771801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tubing deposition, breathing pattern, and temperature on aerosol mass distribution measured by cascade impactor.
    Gurses BK; Smaldone GC
    J Aerosol Med; 2003; 16(4):387-94. PubMed ID: 14977429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosol characteristics of admixture of budesonide inhalation suspension with a beta2-agonist, procaterol.
    Itazawa T; Adachi Y; Ito Y; Higuchi O; Mochizuki H; Shimojo N; Inoue T
    Allergol Int; 2013 Mar; 62(1):131-5. PubMed ID: 23348859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.